Answers are grounded in this paper and cite their sources.
Since the creation of induced Pluripotent Stem Cells (iPSCs) ten years ago, hundreds of publications have demonstrated their considerable impact on disease modeling and therapy. In this commentary, we will summarize key milestones, benefits and challenges in the iPSC field. Furthermore, we will highlight blood as an effective and easily accessible source for patient-specific iPSCs derivation in the context of work done in our laboratory and others.
No takes yet. Share an insight, caveat, or question.
Hokayem et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: